• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺癌干细胞:特征与检测方法

Pancreatic cancer stem cells: features and detection methods.

作者信息

Ishiwata Toshiyuki, Matsuda Yoko, Yoshimura Hisashi, Sasaki Norihiko, Ishiwata Shunji, Ishikawa Naoshi, Takubo Kaiyo, Arai Tomio, Aida Junko

机构信息

Division of Aging and Carcinogenesis, Research Team for Geriatric Pathology, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo, 173-0015, Japan.

Department of Pathology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, 173-0015, Japan.

出版信息

Pathol Oncol Res. 2018 Oct;24(4):797-805. doi: 10.1007/s12253-018-0420-x. Epub 2018 Jun 8.

DOI:10.1007/s12253-018-0420-x
PMID:29948612
Abstract

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a high incidence of distant metastasis and recurrence. Cancer stem cells (CSCs), which are pluripotent, self-renewable, and capable of forming tumors, contribute to PDAC initiation and metastasis and are responsible for resistance to chemotherapy and radiation. Three types of experimental methods are commonly used to identify CSCs: CSC-specific marker detection, a sphere-formation assay that reveals cell proliferation under non-adherent conditions, and detection of side-population (SP) cells that possess high intracellular-to-extracellular pump functions. Several CSC-specific markers have been reported in PDACs, including CD133, CD24, CD44, CXCR4, EpCAM, ABCG2, c-Met, ALDH-1, and nestin. There remains controversy regarding which markers are specific to PDAC CSCs and which are expressed alone or in combination in CSCs. Examining characteristics of isolated CSCs and discovering CSC-specific treatment options are important to improve the prognosis of PDAC cases. This review summarizes CSC-detection methods for PDAC, including CSC-marker detection, the sphere-formation assay, and detection of SP cells.

摘要

胰腺导管腺癌(PDAC)是一种侵袭性恶性肿瘤,远处转移和复发的发生率很高。癌症干细胞(CSCs)具有多能性、自我更新能力且能够形成肿瘤,它们促成了PDAC的起始和转移,并导致对化疗和放疗的抗性。通常使用三种实验方法来鉴定CSCs:CSC特异性标志物检测、揭示非贴壁条件下细胞增殖的成球试验,以及检测具有高细胞内到细胞外泵功能的侧群(SP)细胞。在PDAC中已报道了几种CSC特异性标志物,包括CD133、CD24、CD44、CXCR4、EpCAM、ABCG2、c-Met、ALDH-1和巢蛋白。关于哪些标志物是PDAC CSCs特有的,以及哪些在CSCs中单独表达或联合表达,仍存在争议。研究分离出的CSCs的特性并发现CSC特异性治疗方案对于改善PDAC病例的预后很重要。本综述总结了PDAC的CSC检测方法,包括CSC标志物检测、成球试验和SP细胞检测。

相似文献

1
Pancreatic cancer stem cells: features and detection methods.胰腺癌干细胞:特征与检测方法
Pathol Oncol Res. 2018 Oct;24(4):797-805. doi: 10.1007/s12253-018-0420-x. Epub 2018 Jun 8.
2
Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.癌干细胞标志物在胰腺上皮内瘤变和胰腺导管腺癌中的表达。
Int J Oncol. 2012 Oct;41(4):1314-24. doi: 10.3892/ijo.2012.1565. Epub 2012 Jul 23.
3
Nestin and other putative cancer stem cell markers in pancreatic cancer.巢蛋白及胰腺癌中其他假定的癌症干细胞标志物
Med Mol Morphol. 2012 Jun;45(2):59-65. doi: 10.1007/s00795-012-0571-x. Epub 2012 Jun 21.
4
Fetal bovine serum enlarges the size of human pancreatic cancer spheres accompanied by an increase in the expression of cancer stem cell markers.胎牛血清可增大人胰腺癌细胞球的大小,同时增加癌症干细胞标志物的表达。
Biochem Biophys Res Commun. 2019 Jun 18;514(1):112-117. doi: 10.1016/j.bbrc.2019.04.117. Epub 2019 Apr 23.
5
Prognostic value of cancer stem cell marker CD133 expression in pancreatic ductal adenocarcinoma (PDAC): a systematic review and meta-analysis.癌症干细胞标志物CD133表达在胰腺导管腺癌(PDAC)中的预后价值:一项系统评价和荟萃分析
Int J Clin Exp Pathol. 2015 Oct 1;8(10):12084-92. eCollection 2015.
6
Co-Expression of Cancer Stem Cell Markers Corresponds to a Pro-Tumorigenic Expression Profile in Pancreatic Adenocarcinoma.癌症干细胞标志物的共表达与胰腺腺癌中的促肿瘤发生表达谱相对应。
PLoS One. 2016 Jul 14;11(7):e0159255. doi: 10.1371/journal.pone.0159255. eCollection 2016.
7
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies.研究胰腺癌干细胞特征以制定新的治疗策略。
J Vis Exp. 2015 Jun 20(100):e52801. doi: 10.3791/52801.
8
Nestin delineates pancreatic cancer stem cells in metastatic foci of NOD/Shi-scid IL2Rγ(null) (NOG) mice.巢蛋白在NOD/Shi-scid IL2Rγ(缺失)(NOG)小鼠的转移灶中描绘出胰腺癌干细胞。
Am J Pathol. 2014 Mar;184(3):674-85. doi: 10.1016/j.ajpath.2013.11.014. Epub 2014 Jan 9.
9
Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis.癌症干细胞标志物CD24、CD44和CD133在胰腺导管腺癌和慢性胰腺炎中的表达及临床意义
Dis Markers. 2017;2017:3276806. doi: 10.1155/2017/3276806. Epub 2017 Jun 4.
10
Influence of interferon-α on the expression of the cancer stem cell markers in pancreatic carcinoma cells.干扰素-α对胰腺癌细胞中癌症干细胞标志物表达的影响。
Exp Cell Res. 2014 Jun 10;324(2):146-56. doi: 10.1016/j.yexcr.2014.03.020. Epub 2014 Apr 13.

引用本文的文献

1
DSG2 promotes pancreatic cancer stem cell maintenance via support of tumour and macrophage cellular cross-talk.桥粒芯糖蛋白2通过支持肿瘤与巨噬细胞的细胞间相互作用促进胰腺癌干细胞的维持。
Cell Death Dis. 2025 Jul 4;16(1):492. doi: 10.1038/s41419-025-07833-4.
2
Enrichment of ornithine decarboxylase degron transduced colorectal cancer cells for extended application of cancer stem cell models.富含鸟氨酸脱羧酶降解结构域转导的结肠癌细胞,用于癌症干细胞模型的扩展应用。
Sci Rep. 2025 Jul 2;15(1):22886. doi: 10.1038/s41598-025-04277-w.
3
Hsa_circ_0000467 promotes colorectal cancer proliferation and stem cell characteristics by activating the TCF4/Wnt/β-catenin pathway via sponging miR-520g.

本文引用的文献

1
Electron microscopic analysis of different cell types in human pancreatic cancer spheres.人胰腺癌球体中不同细胞类型的电子显微镜分析。
Oncol Lett. 2018 Feb;15(2):2485-2490. doi: 10.3892/ol.2017.7554. Epub 2017 Dec 8.
2
Pancreatic cancer stem cells in patient pancreatic xenografts are sensitive to drozitumab, an agonistic antibody against DR5.在患者胰腺异种移植物中,胰腺癌细胞干细胞对 drozitumab(一种针对 DR5 的激动性抗体)敏感。
J Immunother Cancer. 2016 Jun 21;4:33. doi: 10.1186/s40425-016-0136-y. eCollection 2016.
3
Cancer statistics, 2016.
Hsa_circ_0000467通过吸附miR-520g激活TCF4/Wnt/β-连环蛋白信号通路,从而促进结直肠癌的增殖及干细胞特性。
APL Bioeng. 2025 Apr 25;9(2):026111. doi: 10.1063/5.0252083. eCollection 2025 Jun.
4
Functional Characterization of miR-216a-5p and miR-125a-5p on Pancreatic Cancer Stem Cells.miR-216a-5p和miR-125a-5p对胰腺癌干细胞的功能表征
Int J Mol Sci. 2025 Mar 21;26(7):2830. doi: 10.3390/ijms26072830.
5
Nanotherapeutic strategies exploiting biological traits of cancer stem cells.利用癌症干细胞生物学特性的纳米治疗策略。
Bioact Mater. 2025 Apr 3;50:61-94. doi: 10.1016/j.bioactmat.2025.03.016. eCollection 2025 Aug.
6
Tumor microenvironment acidosis favors pancreatic cancer stem cell properties and metastasis.肿瘤微环境酸中毒有利于胰腺癌干细胞特性及转移。
iScience. 2025 Feb 5;28(3):111956. doi: 10.1016/j.isci.2025.111956. eCollection 2025 Mar 21.
7
Long non-coding RNA MIR4435-2HG modulates pancreatic cancer stem cells and chemosensitivity to gemcitabine by targeting the miR-1252-5p/STAT1.长链非编码RNA MIR4435-2HG通过靶向miR-1252-5p/STAT1调节胰腺癌干细胞及对吉西他滨的化疗敏感性。
J Transl Med. 2025 Feb 7;23(1):165. doi: 10.1186/s12967-025-06128-8.
8
Insights and therapeutic advances in pancreatic cancer: the role of electron microscopy in decoding the tumor microenvironment.胰腺癌的见解与治疗进展:电子显微镜在解读肿瘤微环境中的作用
Front Cell Dev Biol. 2024 Dec 18;12:1460544. doi: 10.3389/fcell.2024.1460544. eCollection 2024.
9
Unveiling the microRNA landscape in pancreatic ductal adenocarcinoma patients and cancer cell models.揭示胰腺导管腺癌患者和癌细胞模型中的 microRNA 图谱。
BMC Cancer. 2024 Oct 24;24(1):1308. doi: 10.1186/s12885-024-13007-w.
10
Cancer stem cells in meningiomas: novel insights and therapeutic implications.脑膜瘤中的癌症干细胞:新见解与治疗意义
Clin Transl Oncol. 2025 Apr;27(4):1438-1459. doi: 10.1007/s12094-024-03728-6. Epub 2024 Sep 24.
癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
4
MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells.MYC/PGC-1α 平衡决定了胰腺癌干细胞的代谢表型和可塑性。
Cell Metab. 2015 Oct 6;22(4):590-605. doi: 10.1016/j.cmet.2015.08.015. Epub 2015 Sep 10.
5
Systemic Administration of Small Interfering RNA Targeting Human Nestin Inhibits Pancreatic Cancer Cell Proliferation and Metastasis.靶向人类巢蛋白的小分子干扰RNA的全身给药抑制胰腺癌细胞的增殖和转移。
Pancreas. 2016 Jan;45(1):93-100. doi: 10.1097/MPA.0000000000000427.
6
New insights into pancreatic cancer stem cells.胰腺癌干细胞的新见解。
World J Stem Cells. 2015 Apr 26;7(3):547-55. doi: 10.4252/wjsc.v7.i3.547.
7
Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.预计 2030 年美国癌症发病与死亡人数:甲状腺癌、肝癌和胰腺癌带来的意外负担。
Cancer Res. 2014 Jun 1;74(11):2913-21. doi: 10.1158/0008-5472.CAN-14-0155.
8
Nestin delineates pancreatic cancer stem cells in metastatic foci of NOD/Shi-scid IL2Rγ(null) (NOG) mice.巢蛋白在NOD/Shi-scid IL2Rγ(缺失)(NOG)小鼠的转移灶中描绘出胰腺癌干细胞。
Am J Pathol. 2014 Mar;184(3):674-85. doi: 10.1016/j.ajpath.2013.11.014. Epub 2014 Jan 9.
9
Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells.二甲双胍靶向人类胰腺癌细胞的代谢阿喀琉斯之踵。
PLoS One. 2013 Oct 18;8(10):e76518. doi: 10.1371/journal.pone.0076518. eCollection 2013.
10
Cytoplasmic expression of LGR5 in pancreatic adenocarcinoma.胰腺腺癌中 LGR5 的细胞质表达。
Front Physiol. 2013 Sep 26;4:269. doi: 10.3389/fphys.2013.00269. eCollection 2013.